| New from NCI |
| FDA Authorizes Blood Test to Assess Risk of Hereditary Cancers |
 |
|
The Food and Drug Administration (FDA) has, for the first time, granted marketing authorization for a blood test that detects genetic changes that pass from parent to child and increase the risk of developing certain cancers.
Read More
|
| Treatment for Early-Stage Kidney Cancer Shows Promise |
 |
|
For some people with kidney cancer, a treatment called stereotactic body radiotherapy (SBRT) appears to be a highly effective treatment when surgery isn’t an option, according to new findings from a clinical trial.
Read More
|
| Monitoring Caregivers' Emotional Health |
 |
|
Distress can harm a caregiver’s mental and physical health, and a caregiver’s distress may also affect the loved one with cancer they’re caring for. But most cancer centers do not screen caregivers or refer them to services that can help.
Read More
|
| First Drug Approved for Advanced Alveolar Soft Part Sarcoma (ASPS) |
 |
|
A clinical trial showed that the rare cancer known as ASPS can be effectively treated with atezolizumab (Tecentriq), leading to its approval by FDA. This immunotherapy is the first drug ever approved for ASPS.
Read More
|
New Approach Could Help Supercharge T-Cell Therapies against Solid Tumors
Researchers at NCI have developed a way to potentially increase the effectiveness of T cell–based immunotherapies, such as CAR T-cell therapy, against solid tumors.
Read More
|
How to Relax Your Mind and Body
Many people with cancer and their caregivers have found that doing relaxation techniques or practicing meditation and mindfulness has helped them lower stress and cope with anxiety. This updated page describes different mind/body techniques and includes exercises to try.
Read More
|
Cancer Pain
Pain is common in people with cancer, but it can almost always be controlled. This updated page describes the causes of cancer pain, how to talk with your health care team about it, and ways to control it.
Read More
|
New FDA Approval for Biliary Tract Cancer
FDA approval for pembrolizumab (Keytruda) now includes certain types of biliary tract cancer, including bile duct cancer and gallbladder cancer. Pembrolizumab is used alone or with other drugs when biliary tract cancer has spread or cannot be removed by surgery.
Read More
|
